Skip to main content
Clinical Trials/NCT05845905
NCT05845905RecruitingNot Applicable

Effects of Remote Ischemic Conditioning on Blood Pressure in Older Patients With Hypertension

Yi Yang1 site in 1 country158 target enrollmentStarted: May 10, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
158
Locations
1
Primary Endpoint
Mean systolic blood pressure

Study Overview

Brief Summary

The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.

Detailed Description

Current studies have shown that remote ischemic conditioning can improve vascular endothelial function and inhibit sympathetic nervous system activity. Thus it may provide some organ protection as well as anti-hypertensive effects. The purpose of this study is to learn about effects of remote ischemic conditioning on blood pressure in older patients with essential hypertension.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to 85 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥65 years and ≤85 years, regardless of gender;
  • History of essential hypertension and clinical systolic blood pressure ≥ 140 mmHg, regardless of whether they are receiving antihypertensive medication;
  • Willing to participate and sign the informed consent.

Exclusion Criteria

  • Secondary hypertension;
  • Clinical blood pressure ≥ 180/110 mmHg or 24-hour mean arterial pressure ≥ 170/100 mmHg;
  • Severe organ dysfunction or failure;
  • Severe hematologic disorders or significant coagulation abnormalities;
  • History of atrial fibrillation or myocardial infarction within 6 months;
  • Individuals who had contraindication of remote ischemic conditioning, such as severe soft tissue injury, fracture or vascular injury in the upper limb, acute or subacute venous thrombosis, arterial occlusive disease, subclavian steal syndrome, etc;
  • Individuals who will or have received anticoagulant therapy with drugs such as dabigatran, rivaroxaban, warfarin, etc;
  • Those who are participating in other clinical research or has participated in other clinical research or has participated in this study within 3 months prior to enrollment;
  • Other conditions that the researchers think are not suitable for the project.

Arms & Interventions

RIC group

Active Comparator

Patients are treated with remote ischemic conditioning (RIC).

Intervention: Remote ischemic conditioning (Procedure)

Sham RIC group

Placebo Comparator

Patients are treated with sham remote ischemic conditioning (sham-RIC).

Intervention: Sham remote ischemic conditioning (Procedure)

Outcomes

Primary Outcomes

Mean systolic blood pressure

Time Frame: 0-7 days

Difference in mean value of systolic blood pressure during RIC/sham-RIC between two groups.

Secondary Outcomes

  • Mean diastolic blood pressure(0-7 days)

Investigators

Sponsor
Yi Yang
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Yi Yang

Vice President of First Hospital of Jilin University

The First Hospital of Jilin University

Study Sites (1)

Loading locations...

Similar Trials